Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Pfizer signs $507m cancer deal with Effector Therapeutics

Pfizer signs $507m cancer deal with Effector Therapeutics

It has already signed previous collaboration deals with Pfizer and Merck KGaA to study tomivosertib in combination with Bavencio (avelumab) and with Merck &Co to evaluate the candidate with blockbuster

New hires at FibroGen, Saniona and Turbine

New hires at FibroGen, Saniona and Turbine Prior to Sobi, Levin held commercial leadership roles of increasing strategic importance at Merck Serono across a number of countries, including the US, Sweden, Switzerland and Israel. ... Jenkins is a biopharma thought leader with over 25 years of

Merck KGaA, Pfizer’s Bavencio improves survival in bladder cancer

Merck KGaA, Pfizer’s Bavencio improves survival in bladder cancer Importantly for Merck KGaA and Pfizer, the drug is the first immunotherapy to achieve improvement in overall survival in the first-line setting in bladder cancer. ... Serono. Although Merck KGaA and Pfizer have not revealed the exact details of the

Sanofi said to be looking at options for $30bn consumer health unit

Sanofi said to be looking at options for $30bn consumer health unit Many have decided either to sell off the divisions in whole or in part – including Novartis, Merck KGaA, Bristol-Myers Squibb and Bayer for example – while GlaxoSmithKline and Pfizer both slimmed

Dupixent gains can’t keep Sanofi on a growth track

Dupixent gains can’t keep Sanofi on a growth track despite greater competition from drugs like Roche’s Ocrevus (ocrelizumab), Novartis’ Mayzent (siponimod) and Merck KGaA’s Mavenclad (cladribine).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
Pills
Tackling antimicrobial resistance on multiple fronts
An urgent change of direction is needed in how we respond to AMR...
Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...

Infographics